As the icon of next-generation CDMOs, KBI Biopharma is driving breakthroughs in biopharmaceutical development and manufacturing that positively impact the lives of patients worldwide.

While KBI Biopharma serves a social purpose at its core, we recognize that there is also a need to take broader responsibility for the impacts of our business activities. To this end, we have aligned with our parent company, JSR Life Sciences’, Sustainability program in our focus and approach to Sustainability.

From an environmental standpoint, we’ve adopted a strategy of “Measure. Minimize. Mitigate.” and our approach is simple: No impactful change is too big to tackle or too small to dismiss. We want to accurately measure and drastically minimize our footprint through the adoption of energy-efficient technologies and processes, waste reduction, and conservation of natural resources and have set ambitious targets to do so.